Across TCGA pan-cancer cohorts, PPIAP67 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of PPIAP67’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where PPIAP67 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PPIAP67 is over-expressed in tumor, although a few such as KICH and UCEC show the opposite, repressed pattern.
HNSC, KICH, and UCEC are the cancer types where PPIAP67 tumor–normal differential expression is most reproducible.